Carocell Bio have achieved an Innovate UK grant to examine the use of one of their compounds as a new treatment to switch off the inflammation seen after a burn that may lead to a reduction of burn pain and a later reduction of burn scarring.
Dr Mike Davies, Carocell Bio’s CEO said: “This is an exciting project that will start on 1st July 2020 after receiving Innovate UK’s grant offer letter. We will be working with local partners, including Wythenshawe Hospital Burns Unit to deliver the project on time and on budget. This project will deliver exciting results and take Carocell Bio to the next stage showing that our topical medicines work in human tissue.”
Carocell Bio will be attending the 38th J.P Morgan Healthcare Conference
UK: +44 (0) 20 3097 1979
UK: +44 (0) 161 532 8751
US: +1 212 863 9902
Carocell Bio, Inc.
500 Delaware Avenue
Carocell Bio Ltd.
Cheadle Royal Business Park
Copyright Carocell Bio Ltd. ©2020